Maternal vaccination and risk of hospitalization for Covid-19 among newborns

  • 1. Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory Confirmed SARS-CoV-2 Infection Based on Pregnancy Status – United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:16411647.

  • 2. De Sisto CL, Wallace B, Simeone RM, et al. Risk of stillbirth among women with and without COVID-19 at hospitalization for childbirth – United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep 2021; 70:16401645.

  • 3. Ass AA, Chemaitelly H, Al Khal A, et al. Efficacy of the SARS-CoV-2 vaccine in the prevention of confirmed infection in pregnant women. JClin Invest 2021; 131 (23):and153662and153662.

  • 4. Dagan N, Barda N, Biron-Shental T, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med 2021; 27:16931695

  • 5. Lipkind HS, Vazquez-Benitez G, De Silva M, et al. Receiving COVID-19 Vaccine During Pregnancy and Preterm or Gestational Age at Birth – Eight Integrated Health Organizations, United States, December 15, 2020 – July 22, 2021. MMWR Morb Mortal Wkly Rep 2022; 71:2630.

  • 6. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings on the safety of Covid-19 mRNA vaccine in pregnant people. N English J Med 2021; 384:22732282.

  • 7. Zauch LH, Wallace B, Smooth AN, et al. Reception of Covid-19 mRNA vaccines and risk of miscarriage. N English J Med 2021; 385:15331535.

  • 8. Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fallen DB, Haberg SE. Covid-19 Vaccination in pregnancy and spontaneous abortion in the first trimester. N English J Med 2021; 385:20082010.

  • 9. Centers for Disease Control and Prevention. COVID-19 vaccines during pregnancy or breastfeeding (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html).

  • 10. Abu Raya B, Edwards KM, Scheifele DW, Halperin SA. Immunization Against Pertussis and Influenza During Pregnancy: A Landscape Review. Lancet Infect Dis 2017; 17 (7):and209and222.

  • 11. Aziz-Baumgartner E, Grohskopf L, Patel M. Realize the potential of maternal flu vaccination. JAMA 2021; 325:22572259.

  • 12. Omer SB. Maternal immunization. N English J Med 2017; 376:12561267.

  • 13. Halasa NB, Olson SM, Staat MA, et al. Efficacy of maternal vaccination with COVID-19 mRNA vaccine during pregnancy against COVID-19 associated hospitalization in infants less than 6 months of age – 17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022; 71:264270.

  • 14. Carlsen EØ, Magnus MC, Oakley L, et al. Association of COVID-19 vaccination during pregnancy with the incidence of SARS-CoV-2 infection in newborns. JAMA Intern Med 2022 June 1 (Epub before print).

  • 15. Mithal LB, Otero S, Shanes ED, Goldstein JA, Miller ES. Umbilical cord blood antibodies after maternal coronavirus vaccination 2019 during pregnancy. Am J Obstet Gynecol 2021; 225:192194.

  • 16. Beharier O, Plitman Mayo R, Raz T, et al. Efficient maternal-neonatal transfer of antibodies to the SARS-CoV-2 vaccine and BNT162b2 mRNA COVID-19. JClin Invest 2021; 131:150319150319.

  • 17. Prabhu M, Murphy EA, Sukhu AC, et al. Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into umbilical cord blood. Ostet Gynecol 2021; 138:278280.

  • 18. Perl SH, Uzan-Yulzari A, Klainer H, et al. Specific antibodies to SARS-CoV-2 in breast milk after COVID-19 vaccination of breastfeeding women. JAMA 2021; 325:20132014.

  • 19. Baird JK, Jensen SM, Urba WJ, Fox BA, Baird JR. SARS-CoV-2 antibodies detected in breast milk after vaccination. J Hum Lact 2021; 37:492498.

  • 20. Yang YJ, Murphy EA, Singh S, et al. Association of gestational age with coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a booster dose of the vaccine with cord antibody levels umbilical and maternal at the time of childbirth. Ostet Gynecol 2022; 139:373380.

  • 21. Trostle ME, Aguero-Rosenfeld ME, Romano AS, JL lighter. High levels of antibodies in the umbilical cord blood of pregnant women vaccinated against COVID-19. Am J Obstet Gynecol MFM 2021; 3:100481100481.

  • 22. Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies between parturient women treated with the BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM 2022; 4:100492100492.

  • 23. Shaken LL, Atyeo CG, Yonker LM, et al. Durability of anti-spike antibodies in infants after maternal vaccination against COVID-19 or a natural infection. JAMA 2022; 327:10871089.

  • 24. Mark KJ, Whitaker M, Agathis NT, et al. Hospitalization of infants and children aged 0-4 years with laboratory confirmed COVID-19 – COVID-NET, 14 states, March 2020-February 2022. MMWR Morb Mortal Wkly Rep 2022; 71:429436.

  • 25. CV Hobbs, Woodworth K, Young CC, et al. Frequency, characteristics and complications of COVID-19 in hospitalized infants. Pediatr Infect Dis J 2022; 41 (3):and81e86.

  • 26. Mølgaard-Nielsen D, Fischer TK, Krause TG, Hviid A. Efficacy of maternal immunization with inactivated trivalent influenza vaccine in pregnant women and their children. J Intern Med 2019; 286:469480.

  • 27. Olson SM, Newham MM, Halasa NB, et al. Vaccine efficacy against life-threatening influenza disease in US children. Clin Infect Dis 2022 January 13 (Epub before print).

  • 28. Chua H, Feng S, Lewnard JA, et al. The use of negative test controls to monitor vaccine efficacy: a systematic review of methodology. Epidemiology 2020; 31:4364.

  • 29. Olson SM, Newham MM, Halasa NB, et al. Efficacy of the BNT162b2 vaccine against critical Covid-19 in adolescents. N English J Med 2022; 386:713723.

  • 30. Olson SM, Newham MM, Halasa NB, et al. Effectiveness of Pfizer-BioNTech mRNA vaccination against hospitalization for COVID-19 among people aged 12-18 – US, June-September 2021. MMWR Morb Mortal Wkly Rep 2021; 70:14831488.

  • 31. Federal Registry Office. Code of Federal Regulations: A point-in-time eCFR system. Title 45 (https://www.ecfr.gov/cgi-bin/text-idx?SID=fc043bd2812f0775fa80066558a6bbcf&mc=true&node=pt45.1.46&rgn=div5#se45.1.46_1102).

  • 32. Razzaghi H., Meghani M, Pingali C, et al. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy – Eight Integrated Health Organizations, United States, December 14, 2020 – May 8, 2021. MMWR Morb Mortal Wkly Rep 2021; 70:895899.

  • 33. Patel MK, Bergeri I, Bresee JS, et al. Evaluation of the efficacy of the post-introduction COVID-19 vaccine: summary of the provisional guidelines of the World Health Organization. Vaccine 2021; 39:40134024.

  • 34. Centers for Disease Control and Prevention. COVID data tracker: proportions of variants (https://covid.cdc.gov/covid-data-tracker/#variant-proportions).

  • 35. Gray KJ, Bordt EA, Atheist C., et al. Coronavirus Disease Vaccine Response 2019 in Pregnant and Lactating Women: A Cohort Study. Am J Obstet Gynecol 2021; 225 (3):303.e1303.e17.

  • 36. Klein NP, Stockwell MS, Demarco M, et al. Efficacy of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in the prevention of COVID-19-associated emergency wards and urgent care meetings and hospitalizations among non-immunocompromised children and adolescents aged 5-17 years – VISION Network, 10 States, April 2021 – January 2022. MMWR Morb Mortal Wkly Rep 2022; 71:352358.

  • 37. Lauro AS, Tenforde MW, Chappell JD, et al. Clinical severity and efficacy of mRNA vaccines against Covid-19 from ommicron, delta and alpha variants SARS-CoV-2 in the United States: prospective observational study. Bmj 2022; 376:e069761e069761.

  • 38. Centers for Disease Control and Prevention. Cumulative archived data: Percentage of pregnant people aged 18 to 49 who received at least one dose of a COVID-19 vaccine during pregnancy in general, by race / ethnicity, and date reported to CDC-Vaccine Safety Datalink * , United States | December 20, 2020 – January 20, 2022 (https://data.cdc.gov/Vaccinations/Cumulative-Data-Percent-of-Pregnant-People-aged-18/4ht3-nbmd/data).

  • 39. Nemet I, Kliker L, lust Y, et al. Third neutralization of the BNT162b2 vaccination of omicron SARS-CoV-2 infection. N English J Med 2022; 386:492494.

  • 40. Thompson MG, Natarajan K, Irving SA, et al. Efficacy of a Third Dose of mRNA Vaccines Against COVID-19 Associated Emergency and Emergency Care Meetings and Adult Admissions During Periods of Predominance of Delta and Omicron Variants – VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022; 71:139145.

  • Leave a Comment